Displaying 10 out of 18 results

  1. Swiss drugmaker Novartis' logo is seen in Stein

    Novartis wins FDA's breakthrough tag for lung cancer hopeful

    Novartis has secured the U.S. Food and Drug Administration's Breakthrough Therapy Designation for its investigational medicine capmatinib, which ...
  2. A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stoc

    AbbVie terminates late-stage lung cancer trial

    AbbVie Inc on Thursday said it will discontinue the late-stage trial testing its experimental treatment for a type of lung cancer after it failed ...
  3. FILE PHOTO: Logo of Swiss drugmaker Roche is seen at its headquarters in Basel

    Roche's Tecentriq recommended for EU approval to treat lung cancer form

    The European Medicine Agency's Committee for Medicinal Products for Human Use has recommended EU approval of Roche's cancer immunotherapy ...
  4. A lit cigarette burns in Sydney, Australia

    Lung cancer screening guidelines may miss more African Americans at risk

    Current lung cancer screening guidelines may need to be less restrictive when it comes to African American smokers, a new study suggests.
  5. FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey

    Merck's Keytruda sets new five-year survival standard for advanced lung cancer

    Nearly a quarter of patients who received Merck & Co's immunotherapy Keytruda as an initial treatment for advanced lung cancer were still alive ...